Drug Patents owned by Taro

1. List of Flo-pred drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7799331 TARO Oral suspension of prednisolone acetate
Oct, 2028

(5 years from now)

Drugs and Companies using PREDNISOLONE ACETATE ingredient

Market Authorisation Date: 17 January, 2008

Treatment: Treatment of asthma; Treatment of allergic reactions

Dosage: SUSPENSION;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic